Responses
Regular and young investigator award abstracts
Cellular therapies
144 RTX-240, an allogeneic engineered red blood cell expressing 4–1BBL and IL-15TP, promotes NK cell functionality in vitro and in vivo
Compose a Response to This Article
Other responses
No responses have been published for this article.
